ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Monotropein attenuates apoptosis and pyroptosis in chondrocytes and alleviates osteoarthritis progression in mice

Li, Zhen; Chen, Zhenyue; Chen, Jiayi; Liu, Zhutong; Li, Zehui; Sun, He; Wang, Xiaochao; Wei, Jinqiang; Cao, Xuewei*; Zheng, Decai*广东省人民医院; 广州中医药大学; 1
Chinese Medicine2023-4-19DOI: 10.1186/s13020-023-00748-2
2被引9阅读
引用收藏
分享

摘要

BackgroundOsteoarthritis (OA) is a chronic degenerative joint disease characterized by loss of joint function, which seriously reduces the quality of life of the elderly and imposes a heavy socioeconomic burden worldwide. Monotropein (MON), the main active ingredient of Morinda officinalis F.C. How, has exhibited therapeutic effects in different disease models. However, its potential effects on chondrocytes in an arthritic model remain unclear. This study aimed to evaluate the effects of MON in chondrocytes and a mouse model of OA, and explore the potential mechanisms. Materials and methodsMurine primary chondrocytes were pretreated with 10 ng/ml interleukin (IL)-1 beta for 24 h to establish an in vitro model of OA, and then treated with different concentrations of MON (0, 25, 50 and 100 mu M) for 24 h. The proliferation of the chondrocytes was assayed using ethynyl-deoxyuridine (EdU) staining. Immunofluorescence staining, western blotting and TUNEL staining were performed to assess the effects of MON on cartilage matrix degradation, apoptosis and pyroptosis. The mouse model of OA was constructed by surgical destabilization of the medial meniscus (DMM), and the animals were randomly divided into the sham-operated, OA and OA + MON groups. Following OA induction, the mice were given intraarticular injection of 100 mu M MON or equal volume of normal saline twice a week for 8 weeks. The effects of MON on cartilage matrix degradation, apoptosis and pyroptosis were assessed as indicated. ResultsMON significantly accelerated the proliferation of chondrocytes, and inhibited cartilage matrix degradation, apoptosis and pyroptosis in the IL-1 beta-stimulated cells by blocking the nuclear factor-kappa B (NF-kappa B) signaling pathway. In the mouse model as well, MON treatment alleviated OA progression and promoted cartilage repair by inhibiting cartilage matrix degradation, and chondrocyte apoptosis and pyroptosis through the inactivation of the NF-kappa B signaling pathway. Furthermore, the MON-treated arthritic mice exhibited better articular tissue morphology and lower OARSI scores. ConclusionsMON alleviated OA progression by inhibiting cartilage matrix degradation, and the apoptosis and pyroptosis of chondrocytes via NF-kappa B pathway inactivation, and is a promising alternative for the treatment of OA.

学科与关键词

关键词
MonotropeinOsteoarthritisCartilage matrix degradationApoptosisPyroptosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Chinese Medicine
发表日期
2023-04-19
卷期
第 18 卷, 第 1 期
页码
42
DOI
10.1186/s13020-023-00748-2
语言
ENGLISH
成果收录
SCIE

作者

  • L

    Li, Zhen (第一作者)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • C

    Chen, Zhenyue

    1

查看全部 10 位作者收起作者
  • C

    Chen, Jiayi

    guangzhou univ tradit chinese med

  • L

    Liu, Zhutong

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Li, Zehui

    2 · guangdong prov hosp · guangzhou univ chinese med

  • S

    Sun, He

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wang, Xiaochao

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wei, Jinqiang

    2 · guangdong prov hosp · guangzhou univ chinese med

  • C

    Cao, Xuewei (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zheng, Decai (通讯)

    guangdong prov hosp · 2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417